1. Home
  2. QTTB vs URG Comparison

QTTB vs URG Comparison

Compare QTTB & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • URG
  • Stock Information
  • Founded
  • QTTB 2015
  • URG 2004
  • Country
  • QTTB United States
  • URG United States
  • Employees
  • QTTB N/A
  • URG N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • URG Precious Metals
  • Sector
  • QTTB Health Care
  • URG Basic Materials
  • Exchange
  • QTTB Nasdaq
  • URG Nasdaq
  • Market Cap
  • QTTB 434.0M
  • URG 458.8M
  • IPO Year
  • QTTB N/A
  • URG N/A
  • Fundamental
  • Price
  • QTTB $3.31
  • URG $1.15
  • Analyst Decision
  • QTTB Buy
  • URG Strong Buy
  • Analyst Count
  • QTTB 8
  • URG 2
  • Target Price
  • QTTB $29.14
  • URG $2.45
  • AVG Volume (30 Days)
  • QTTB 690.6K
  • URG 3.7M
  • Earning Date
  • QTTB 11-07-2024
  • URG 11-06-2024
  • Dividend Yield
  • QTTB N/A
  • URG N/A
  • EPS Growth
  • QTTB N/A
  • URG N/A
  • EPS
  • QTTB N/A
  • URG N/A
  • Revenue
  • QTTB N/A
  • URG $16,494,000.00
  • Revenue This Year
  • QTTB N/A
  • URG $86.92
  • Revenue Next Year
  • QTTB N/A
  • URG $73.30
  • P/E Ratio
  • QTTB N/A
  • URG N/A
  • Revenue Growth
  • QTTB N/A
  • URG 34.78
  • 52 Week Low
  • QTTB $3.02
  • URG $0.96
  • 52 Week High
  • QTTB $53.79
  • URG $2.01
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 16.87
  • URG 41.50
  • Support Level
  • QTTB $3.02
  • URG $1.09
  • Resistance Level
  • QTTB $3.77
  • URG $1.18
  • Average True Range (ATR)
  • QTTB 1.69
  • URG 0.06
  • MACD
  • QTTB -0.34
  • URG -0.01
  • Stochastic Oscillator
  • QTTB 1.16
  • URG 26.09

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About URG Ur Energy Inc (Canada)

Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.

Share on Social Networks: